Unfortunately we won't see the order within 6 months (if they continue to appeal it will be still at FDA) and FDA did not breach the SPA, it was terminated entirely by them.
The Anchor FDA stated that the Anchor sNDA would be accepted for review ONLY AFTER the R-IT study was 50% enrolled. Now the FDA is maintaining that that the Anchor SPA and Anchor sNDA are TOTALLY unrelated issues. Huh? What kind of logic is that?
Unfortunately we won't see the order within 6 months (if they continue to appeal it will be still at FDA) and FDA did not breach the SPA, it was terminated entirely by them.
You seem to be of the opinion the FDA will lose in court but did not breach the agreeement?
If AMRN doesn't appeal to the courts (ie stays within the FDA) how will they ever see a court order.